Effects of progestagens and Org OD14 in in vitro and in vivo tumor models

Journal of Steroid Biochemistry and Molecular Biology

Volumn 49, Issue 4-6, 1994, Pages 311-318

  Kloosterboer, H J ^a   Schoonen, W G E J ^a   Deckers, G H ^a   Klijn, J G M ^b  

^a NV ORGANON   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA [4 (DIMETHYLAMINO)PHENYL] 4',5' DIHYDRO 6BETA METHYLSPIRO[ESTRA 4,9 DIENE 17BETA,2'(3'H) FURAN] 3 ONE; 4 HYDROXYTAMOXIFEN; BENZ[A]ANTHRACENE DERIVATIVE; ETONOGESTREL; GESTAGEN; GESTODENE; MIFEPRISTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NORETHISTERONE; PROGESTERONE; TIBOLONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; CELL LINE; MAMMARY NEOPLASMS, EXPERIMENTAL; NORPREGNENES; PROGESTATIONAL HORMONES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0028114085     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(94)90273-9     Document Type: Article

References (31)

1. Role of sex steroid hormones in normal mammary gland function
2. Breast epithelial responses and steroid receptors during oral contraceptive use
3. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells
4. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T-47-D
5. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
6. Multiple actions of synthetic progestins on the growth of ZR-75-1 human breast cancer cells: an in vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids
7. Influence of culture conditions on the estrogenic cell grwoth stimulation on human breast cancer cells
8. Growth stimulation and differential regulation of transforming growth factor β1 (TGFβ1), TGFβ2, and TGFβ3 messenger RNA levels by norethisterone in MCF-7 breast tumor cells
9. Effects of progestins on the proliferation of estrogen-dependent human breast tumor on cells under growth factor-defined conditions
10. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation
11. The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta
12. Effects of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells
13. Progestin regulation of cellular proliferation
14. Difference between R5020 and the antiprogestagen RU486 in antiproliferative effects on human breast cancer cells
15. Progestin effects on growth in the human breast cancer cell line T-47-D; possible therapeutic implications
16. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture
17. A novel binding site for a synthetic progestagen in breast cancer
18. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression
19. Influence of underfeeding during the “critical period” or thereafter on carcinogen induced mammary tumors in rats
20. Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat
21. Effects of progesterone and R2323 on the development of dimethylbenzathracene-induced mammary tumors
22. Biology of disease: Biological and molecular base of mammary carcinogenesis
23. Contraceptives as hormone-preventive agents in mammary carcinogenesis
24. Influence of two contraceptives on induction of mammary cancer in rats
25. Endocrinological studies with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one(Org OD14)
26. Use of Org OD14 for the treatment of climacteric complaints
27. Clinical profile of Org OD14
28. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives
29. Treatment of breast cancer with different anti-progestins preclinical and clinical studies
30. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos and c-myc genes
31. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD14) and its metabolites on human endometrium